ASTRAZENECA PLC (AZN)
Clinical trial NCT05951959 updates: 1. completion date: 2028-07-07 → 2028-10-31 2. primary completion date: 2028-07-07 → 2028-10-31
Clinical trial NCT05951959 updates: 1. completion date: 2028-07-07 → 2028-10-31 2. primary completion date: 2028-07-07 → 2028-10-31
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical